Kodiak Sciences (KOD) stock
NASDAQ
As of the Nov 17, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $6.29B
- As of Nov 17, 2026
- P/E
- -25.37x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- Not available
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 17, 2026 and may differ from the current price.
- Market cap
- $6.29B
- As of Nov 17, 2026
- P/E
- -25.37x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- Not available
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 17, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
-25.37x
Net loss — not comparable
P/B
—
P/S
—
Earnings and dividend metrics▾
Earnings
EPS
-$3.82
Earnings per share
BPS
—
Book value per share
ROE
—
Return on equity
- EPS — what one share earned over the last four quarters. The company is currently loss-making, at $3.82 per share.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Operating income decreased from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Operating income · same quarter, three years
Year-ago quarter -$62MDown
-$47M
Jul–Sep '24
-$62M
Jul–Sep '25
-$67M
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Nov 12, 2026.
- Earnings per share increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
- Operating income decreased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
- Net income decreased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
Filed Nov 12, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- BAKER BROS. ADVISORS LPDirector · Nov 5, 2026Open-market purchase86,432 shares · $8.5MAvg. price $98.51
Show 2 price lots
- 81,729 shares × $98.51$8.1M
- 4,703 shares × $98.51$463K
- BAKER BROS. ADVISORS LPDirector · Nov 4, 2026Open-market purchase160,658 shares · $15.8MAvg. price $98.51
Show 2 price lots
- 151,916 shares × $98.51$15.0M
- 8,742 shares × $98.51$861K
- Yang TaiyinDirector · Oct 23, 2026Option exercise20,000 shares · $47KAvg. price $2.3520,000 shares held after
- BORGESON JOHN A.Chief Financial Officer · Oct 21, 2026Open-market sale30,000 shares · $2.7MAvg. price $90.0107
Show 8 price lots
- 8,514 shares × $87.67$746K
- 7,623 shares × $89.74$684K
- 5,101 shares × $90.98$464K
- 2,985 shares × $91.76$274K
- 2,000 shares × $93.71$187K
- 2,000 shares × $92.66$185K
- 1,677 shares × $89.2$150K
- 100 shares × $94.91$9K
- BORGESON JOHN A.Chief Financial Officer · Oct 21, 2026Option exercise30,000 shares · $75KAvg. price $2.49241,930 shares held after
- BAKER BROS. ADVISORS LPDirector · Sep 29, 2026Open-market purchase33,726 shares · $2.9MAvg. price $85.0458
Show 6 price lots
- 20,031 shares × $85.403$1.7M
- 10,381 shares × $84.2421$875K
- 1,416 shares × $85.8855$122K
- 1,195 shares × $85.403$102K
- 619 shares × $84.2421$52K
- 84 shares × $85.8855$7K
- BAKER BROS. ADVISORS LPDirector · Sep 28, 2026Open-market purchase1,654,838 shares · $134.3MAvg. price $81.1669
Show 20 price lots
- 278,978 shares × $72.3873$20.2M
- 196,608 shares × $89.8555$17.7M
- 123,888 shares × $83.9512$10.4M
- 107,772 shares × $88.646$9.6M
- 109,842 shares × $84.8543$9.3M
- 98,561 shares × $88.5671$8.7M
- 82,673 shares × $89.6036$7.4M
- 75,176 shares × $87.5065$6.6M
- 78,726 shares × $73.0777$5.8M
- 76,723 shares × $73.9686$5.7M
- 63,539 shares × $86.9421$5.5M
- 61,700 shares × $76.345$4.7M
- 49,771 shares × $78.5681$3.9M
- 48,350 shares × $77.4314$3.7M
- 38,932 shares × $85.9656$3.3M
- 44,690 shares × $61.6252$2.8M
- 39,066 shares × $68.9578$2.7M
- 32,261 shares × $75.5151$2.4M
- 28,028 shares × $81.8162$2.3M
- 19,554 shares × $83.1552$1.6M
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsFilings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Kodiak Sciences (KOD) stock information
NASDAQ
Kodiak Sciences (KOD) is listed on NASDAQ. Its market capitalization is about $6.3B. On trailing-twelve-month earnings the P/E ratio is -25.37. These figures are computed in-house from official filings and are reference information only.
Kodiak Sciences — frequently asked questions
- What is the P/E ratio of Kodiak Sciences (KOD)?
- On a trailing-twelve-month basis, KOD trades at a P/E ratio of -25.37. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Kodiak Sciences?
- KOD has a market capitalization of about $6.3B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.